Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign Nanotech Investing
Satellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress Nanotech Investing
Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update Nanotech Investing
Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update Nanotech Investing
Zipalertinib Plus Chemotherapy Meets Primary Endpoint of Progression-Free Survival in Planned Interim Analysis of Phase 3 REZILIENT3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer Nanotech Investing
Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update Nanotech Investing
Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition Nanotech Investing
Sona Nanotech Closes Over-Subscribed Private Placement Financing to Raise $2,527,012 in Gross Proceeds Nanotech Investing
Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference Nanotech Investing
Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress Nanotech Investing
